Related Experiment Video
Updated: Oct 27, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
In silico model for miRNA-mediated regulatory network in cancer
Khandakar Tanvir Ahmed1, Jiao Sun1, William Chen1
1Department of Computer Science, University of Central Florida, Orlando, FL 32816, USA.
Abstract:
Deregulation of gene expression is associated with the pathogenesis of numerous human diseases including cancer. Current data analyses on gene expression are mostly focused on differential gene/transcript expression in big data-driven studies. However, a poor connection to the proteome changes is a widespread problem in current data analyses. This is partly due to the complexity of gene regulatory pathways at the post-transcriptional level. In this study, we overcome these limitations and introduce a graph-based learning model, PTNet, which simulates the microRNAs (miRNAs) that regulate gene expression post-transcriptionally in silico. Our model does not require large-scale proteomics studies to measure the protein expression and can successfully predict the protein levels by considering the miRNA-mRNA interaction network, the mRNA expression, and the miRNA expression. Large-scale experiments on simulations and real cancer high-throughput datasets using PTNet validated that (i) the miRNA-mediated interaction network affects the abundance of corresponding proteins and (ii) the predicted protein expression has a higher correlation with the proteomics data (ground-truth) than the mRNA expression data. The classification performance also shows that the predicted protein expression has an improved prediction power on cancer outcomes compared to the prediction done by the mRNA expression data only or considering both mRNA and miRNA. Availability: PTNet toolbox is available at http://github.com/CompbioLabUCF/PTNet.
Insights
This study introduces PTNet, a novel graph-based model predicting protein levels from gene and microRNA expression. PTNet accurately links gene regulation to protein abundance, improving cancer outcome predictions.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Gene expression deregulation is key in human diseases like cancer.
- Current analyses focus on gene/transcript levels, often lacking proteomic correlation.
- Post-transcriptional regulation by microRNAs (miRNAs) complicates direct gene-to-protein links.
Purpose of the Study:
- To develop a computational model, PTNet, for predicting protein expression from miRNA and mRNA data.
- To overcome limitations in connecting gene expression to proteomic changes.
- To establish a tool for improved understanding of gene regulation in disease.
Main Methods:
- Developed a graph-based learning model, PTNet.
- Integrated miRNA-mRNA interaction networks, mRNA expression, and miRNA expression data.
- Validated the model using simulations and real cancer high-throughput datasets.
Main Results:
- PTNet successfully predicts protein levels without direct proteomics data.
- miRNA-mediated interactions significantly impact protein abundance.
- Predicted protein expression shows higher correlation with proteomics data than mRNA expression.
- Predicted protein levels improve cancer outcome classification accuracy.
Conclusions:
- PTNet effectively models post-transcriptional regulation by miRNAs.
- The model provides a more accurate link between gene expression and protein levels.
- PTNet enhances predictive power for cancer outcomes, offering a valuable tool for research.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

